Post-transplant upregulation of chemokine messenger RNA in non-human primate recipients of intraportal pig islet xenografts

Xenotransplantation

Volumn 12, Issue 4, 2005, Pages 293-302

  Hårdstedt, Maria ^a,b   Finnegan, Colleen P ^c   Kirchhof, Nicole ^a   Hyland, Kendra A ^c   Wijkstrom, Martin ^a   Murtaugh, Michael P ^c   Hering, Bernhard J ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Chemokines; CXCR3; Intragraft gene expression; Islet xenograft rejection; Non human primate; Xenotransplantation

Indexed keywords

CHEMOATTRACTANT; CHEMOKINE; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; CYCLOPHILIN; FAS LIGAND; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANZYME B; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOKINE; PERFORIN; PIG INSULIN; RANTES;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLUSTER ANALYSIS; CYTOLYSIS; CYTOTOXICITY; FEMALE; GENE EXPRESSION; GRAFT REJECTION; HISTOLOGY; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LIVER; LYMPHOCYTE; MACROPHAGE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PRIMATE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHESUS MONKEY; RNA EXTRACTION; SWINE; T LYMPHOCYTE; XENOGRAFT;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; CHEMOKINES; CYTOKINES; FEMALE; GENE EXPRESSION PROFILING; INFLAMMATION; ISLETS OF LANGERHANS TRANSPLANTATION; MACACA; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RNA, MESSENGER; SPECIES SPECIFICITY; SWINE; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSPLANTATION, HETEROLOGOUS; UP-REGULATION;

EID: 20944446344     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2005.00228.x     Document Type: Article

References (32)

1. SCHMIDT P, KROOK H, MAEDA A et al. A new murine model of islet xenograft rejection: graft destruction is dependent on a major histocompatibility-specific interaction between T-cells and macrophages. Diabetes 2003; 52: 1111.
2. KROOK H, HAGBERG A, SONG Z et al. A distinct Th1 immune response precedes the described Th2 response in islet xenograft rejection. Diabetes 2002; 51: 79.
3. BUHLER L, DENG S, O'NEIL J et al. Adult porcine islet transplantation in baboons treated with conventional immunosuppression or a non-myeloablative regimen and CD 154 blockade. Xenotransplantation 2002; 9: 3.
4. CANTAROVICH D, BLANCHO G, POTIRON N et al. Rapid failure of pig islet transplantation in nonhuman primates. Xenotransplantation 2002; 9: 25.
5. KIRCHHOF N, SHIBATA S, WIJKSTROM M et al. Reversal of diabetes in non-immunosuppressed rhesus macaques by intraportal porcine islet xenografts precedes acute cellular rejection. Xenotransplantation 2004; 11: 396.
6. INSTON NG, COCKWELL P. The evolving role of chemokines and their receptors in acute allograft rejection. Nephrol Dial Transplant 2002; 17: 1374.
7. EL-SAWY T, FAHMY NM, FAIRCHILD RL. Chemokines: directing leukocyte infiltration into allografts. Curr Opin Immunol 2002; 14: 562.
8. HANCOCK WW, GAO W, FAIA KL, CSIZMADIA V. Chemokines and their receptors in allograft rejection. Curr Opin Immunol 2000; 12: 511.
9. ANONYMOUS. User Bulletin No. 2, Relative quantification of gene expression. ABI 7700 Sequence Detection System 1997, updated 2001. Foster City, CA: Applied Biosystem.
10. RAMAKERS C, RUIJTER JM, DEPREZ RH, MOORMAN AF. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 2003; 339: 62.
11. BAR T, STAHLBERG A, MUSZTA A, KUBISTA M. Kinetic Outlier Detection (KOD) in real-time PCR. Nucleic Acids Res 2003; 31: e105.
12. EISEN MB, SPELLMAN PT, BROWN PO, BOTSTEIN D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998; 95: 14863.
13. MURPHY PM, BAGGIOLINI M, CHARO IF et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 2000; 52: 145.
14. OLSON TS, LEY K. Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol Regul Integr Comp Physiol 2002; 283: R7.
15. HANCOCK WW, LU B, GAO W et al. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med 2000; 192: 1515.
16. AGOSTINI C, CALABRESE F, REA F et al. CXCR3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. Am J Pathol 2001; 158: 1703.
17. ZHAO DX, HU Y, MILLER GG et al. Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection. J Immunol 2002; 169: 1556.
18. ABDI R, MEANS TK, LUSTER AD. Chemokines in islet allograft rejection. Diabetes Metab Res Rev 2003; 19: 186.
19. SCHROPPEL B, ZHANG N, CHEN P et al. Differential expression of chemokines and chemokine receptors in murine islet allografts: the role of CCR2 and CCR5 signaling pathways. J Am Soc Nephrol 2004; 15: 1853.
20. BAKER MS, CHEN X, ROTRAMEL AR et al. Genetic deletion of chemokine receptor CXCR3 or antibody blockade of its ligand IP-10 modulates posttransplantation graft-site lymphocytic infiltrates and prolongs functional graft survival in pancreatic islet allograft recipients. Surgery 2003; 134: 126.
21. PAULE MF, McCoLL SR, SIMEONOVIC CJ. Murine chemokine gene expression in rejecting pig proislet xenografts. Transplant Proc 2000; 32: 1062.
22. SOLOMON MF, KUZIEL WA, MANN DA, SIMEONOVIC CJ. The role of chemokines and their receptors in the rejection of pig islet tissue xenografts. Xenotransplantation 2003; 10: 164.
23. GAO W, TOPHAM PS, KING JA et al. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. J Clin Invest 2000; 105: 35.
24. ABDI R, MEANS TK, ITO T et al. Differential role of CCR2 in islet and heart allograft rejection: tissue specificity of chemokine/chemokine receptor function in vivo. J Immunol 2004; 172: 767.
25. ABDI R, SMITH RN, MAKHLOUF L et al. (CCR5) in islet allograft rejection. Diabetes 5 2002; 2489.
26. LEE I, WANG L, WELLS AD et al. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism. J Immunol 2003; 171: 6929.
27. SALLUSTO F, LANZAVECCHIA A. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol Rev 2000; 177: 134.
28. SALLUSTO F, LENIG D, FORSTER R et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401: 708.
29. UNSOELD H, KRAUTWALD S, VOEHRINGER D et al. Cutting edge: CCR7+ and CCR7- memory T cells do not differ in immediate effector cell function. J Immunol 2002; 169: 638.
30. YI S, FENG X, HAWTHORNE W et al. CD8+ T cells are capable of rejecting pancreatic islet xenografts. Transplantation 2000; 70: 896.
31. SODERLUND J, WENNBERG L, CASTANOS-VELEZ E et al. Fetal porcine islet-like cell clusters transplanted to cynomolgus monkeys: an immunohistochemical study. Transplantation 1999; 67: 784.
32. YI S, FENG X, WANG Y et al. CD4+ cells play a major role in xenogeneic human anti-pig cytotoxicity through the Fas/Fas ligand lytic pathway. Transplantation 1999; 67: 435.